Innovative Pharmaceutical Biotech Limited (0399.HK)
HKD 0.18
(-1.67%)
HKD 0.18
(-1.67%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 317.74 Million HKD | 33.62% |
| 2022 | -18.82 Million HKD | 15.31% |
| 2021 | -22.3 Million HKD | -16.76% |
| 2020 | -18.81 Million HKD | 23.17% |
| 2019 | -80.49 Million HKD | -114.56% |
| 2018 | -129.15 Million HKD | -84.09% |
| 2017 | -119.64 Million HKD | -1939.3% |
| 2016 | -69.13 Million HKD | 102.44% |
| 2015 | -160.22 Million HKD | 62.39% |
| 2014 | -402.69 Million HKD | -15.85% |
| 2013 | -32.03 Million HKD | 39.63% |
| 2012 | -37.18 Million HKD | -182.1% |
| 2011 | -125.35 Million HKD | 496.97% |
| 2010 | 10.82 Million HKD | -22.37% |
| 2009 | 13.94 Million HKD | -98.14% |
| 2008 | 748.05 Million HKD | 13651.13% |
| 2007 | -5.52 Million HKD | -562.79% |
| 2006 | -833 Thousand HKD | -161.95% |
| 2005 | 881 Thousand HKD | 87.73% |
| 2004 | -2.59 Million HKD | 93.98% |
| 2003 | -43.06 Million HKD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 FY | - HKD | 33.62% |
| 2023 Q1 | -2.63 Million HKD | 78.54% |
| 2023 Q2 | -5.45 Million HKD | -107.11% |
| 2023 Q3 | -3.17 Million HKD | 41.86% |
| 2023 Q4 | -7.1 Million HKD | -123.71% |
| 2022 Q3 | -6.07 Million HKD | 10.17% |
| 2022 Q4 | -12.28 Million HKD | -102.06% |
| 2022 Q1 | -3.32 Million HKD | 61.58% |
| 2022 Q2 | -6.76 Million HKD | -103.73% |
| 2022 FY | - HKD | 15.31% |
| 2021 FY | - HKD | -16.76% |
| 2021 Q1 | -7.34 Million HKD | -9.3% |
| 2021 Q2 | -13.57 Million HKD | -84.77% |
| 2021 Q3 | -4.85 Million HKD | 64.28% |
| 2021 Q4 | -8.64 Million HKD | -78.22% |
| 2020 Q2 | -6.47 Million HKD | -83.24% |
| 2020 FY | - HKD | 23.17% |
| 2020 Q3 | -7.24 Million HKD | -12.01% |
| 2020 Q1 | -3.53 Million HKD | 55.73% |
| 2020 Q4 | -6.72 Million HKD | 7.24% |
| 2019 FY | - HKD | -114.56% |
| 2019 Q1 | -5.9 Million HKD | 23.66% |
| 2019 Q2 | -11.8 Million HKD | -100.0% |
| 2019 Q3 | -10.24 Million HKD | 13.15% |
| 2019 Q4 | -7.97 Million HKD | 22.16% |
| 2018 Q3 | -7.72 Million HKD | -35.55% |
| 2018 Q4 | -7.72 Million HKD | 0.0% |
| 2018 Q2 | -5.7 Million HKD | 0.0% |
| 2018 Q1 | -5.7 Million HKD | 43.29% |
| 2018 FY | - HKD | -84.09% |
| 2017 FY | - HKD | -1939.3% |
| 2017 Q3 | -10.05 Million HKD | -368.55% |
| 2017 Q2 | -2.14 Million HKD | 0.0% |
| 2017 Q1 | -2.14 Million HKD | 65.75% |
| 2017 Q4 | -10.05 Million HKD | 0.0% |
| 2016 Q4 | -6.26 Million HKD | 0.0% |
| 2016 Q1 | -4.47 Million HKD | 58.8% |
| 2016 Q2 | -4.47 Million HKD | 0.0% |
| 2016 Q3 | -6.26 Million HKD | -40.03% |
| 2016 FY | - HKD | 102.44% |
| 2015 Q1 | -4.06 Million HKD | 45.51% |
| 2015 Q3 | -10.86 Million HKD | -167.15% |
| 2015 Q2 | -4.06 Million HKD | 0.0% |
| 2015 Q4 | -10.86 Million HKD | 0.0% |
| 2015 FY | - HKD | 62.39% |
| 2014 Q1 | -7.71 Million HKD | 0.0% |
| 2014 FY | - HKD | -15.85% |
| 2014 Q4 | -7.46 Million HKD | -1.46% |
| 2014 Q3 | -7.35 Million HKD | 4.64% |
| 2014 Q2 | -7.71 Million HKD | 0.0% |
| 2013 FY | - HKD | 39.63% |
| 2013 Q2 | -10.19 Million HKD | 16.39% |
| 2013 Q4 | - HKD | 0.0% |
| 2013 Q1 | -12.19 Million HKD | -1.49% |
| 2012 Q2 | -6.48 Million HKD | 0.0% |
| 2012 Q4 | -12.01 Million HKD | -85.25% |
| 2012 Q3 | -6.48 Million HKD | 0.0% |
| 2012 FY | - HKD | -182.1% |
| 2011 FY | - HKD | 496.97% |
| 2010 FY | - HKD | -22.37% |
| 2009 FY | - HKD | -98.14% |
| 2008 FY | - HKD | 13651.13% |
| 2007 FY | - HKD | -562.79% |
| 2006 FY | - HKD | -161.95% |
| 2005 FY | - HKD | 87.73% |
| 2004 FY | - HKD | 93.98% |
| 2003 FY | - HKD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | 22.91 Million HKD | -1286.806% |
| China Overseas Nuoxin International Holdings Limited | 2.02 Million HKD | -15560.177% |
| Prosperous Future Holdings Limited | -19.68 Million HKD | 1714.066% |
| Huasheng International Holding Limited | 19.67 Million HKD | -1514.722% |
| Fourace Industries Group Holdings Limited | 61.52 Million HKD | -416.449% |
| Evergreen Products Group Limited | 140.78 Million HKD | -125.7% |
| EC Healthcare | 737.83 Million HKD | 56.935% |
| Ming Fai International Holdings Limited | 211.83 Million HKD | -49.997% |
| Blue Moon Group Holdings Limited | 656.37 Million HKD | 51.591% |
| SuperRobotics Holdings Limited | -7.39 Million HKD | 4394.432% |
| Takbo Group Holdings Limited | 25.8 Million HKD | -1131.379% |
| Hyfusin Group Holdings Limited | 154.18 Million HKD | -106.078% |